VeriMom¿Es buxus sempervirens leaf extract seguro durante el embarazo?
No EU restriction or ban listed for Buxus sempervirens extract in the EU cosmetics inventory (INCI entry present), and there are no SCCS or CIR safety assessments or harmonised CLP (Annex VI) CMR classifications identified for the cosmetic extract. Published toxicology about Buxus species reports steroidal alkaloids (e.g., cyclobuxine) that cause systemic toxicity after ingestion, but I did not find peer‑reviewed reproductive or developmental studies on the cosmetic leaf extract showing teratogenicity or reproductive effects; therefore hazard = 0 and mechanism = 0. Topical cosmetic exposure is expected to be low but measurable, so exposure = 1.
Related ingredients
Frequently asked questions
- ¿Es buxus sempervirens leaf extract seguro durante el embarazo?
- No EU restriction or ban listed for Buxus sempervirens extract in the EU cosmetics inventory (INCI entry present), and there are no SCCS or CIR safety assessments or harmonised CLP (Annex VI) CMR classifications identified for the cosmetic extract. Published toxicology about Buxus species reports steroidal alkaloids (e.g., cyclobuxine) that cause systemic toxicity after ingestion, but I did not find peer‑reviewed reproductive or developmental studies on the cosmetic leaf extract showing teratogenicity or reproductive effects; therefore hazard = 0 and mechanism = 0. Topical cosmetic exposure is expected to be low but measurable, so exposure = 1.
- ¿Es buxus sempervirens leaf extract seguro durante la lactancia?
- Same evidence base as for pregnancy: no regulatory bans/restrictions (EU Annex II/III), no harmonised H361/H360 classification, and no breastfeeding‑specific toxicity or transfer data for the cosmetic leaf extract. Ingestion of whole plant is known to be toxic (steroidal alkaloids), but that does not constitute evidence of reproductive/lactation hazard from topical cosmetic use; exposure from dermal use is low but measurable.
- ¿Es buxus sempervirens leaf extract seguro para la piel del bebé?
- No infant‑specific reproductive or developmental toxicity data were identified for the cosmetic extract. Because infant skin has a higher surface‑area‑to‑body‑weight ratio and an immature barrier, I increased exposure by +1 relative to the adult dermal exposure score; there is still no evidence of a reproductive mechanism or harmonised classification for the cosmetic ingredient itself.
- ¿Cómo puntúa VeriMom a buxus sempervirens leaf extract?
- VeriMom puntúa buxus sempervirens leaf extract en 93/100 (sin riesgos conocidos) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a buxus sempervirens leaf extract en el embarazo?
- Consulta nuestra lista de alternativas seguras a buxus sempervirens leaf extract según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.